seekingalpha.com
Hyperfine, Inc. (HYPR) Q4 2025 Earnings Call Transcript
Hyperfine, Inc. (HYPR) Q4 2025 Earnings Call Transcript
Hyperfine, Inc.HYPRNASDAQ
Loading
Latest News
Loading news...
businesswire.com
Hyperfine, Inc. Reports Fourth Quarter and Full Year 2025 Financial Results
GUILFORD, Conn.--(BUSINESS WIRE)--Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking health technology company that has redefined brain imaging with the first FDA-cleared AI-powered portable magnetic resonance (MR) brain imaging system—the Swoop® system—today announced fourth quarter and full year 2025 financial results and provided a business update. “The launch of our second-generation Swoop® scanner, our Optive AI™ software, and the addition of a new market in the neurology office setting in.
defenseworld.net
Analyzing Hyperfine (NASDAQ:HYPR) and Arrayit (OTCMKTS:ARYC)
Hyperfine (NASDAQ: HYPR - Get Free Report) and Arrayit (OTCMKTS:ARYC - Get Free Report) are both medical companies, but which is the better investment? We will compare the two companies based on the strength of their analyst recommendations, risk, dividends, valuation, earnings, institutional ownership and profitability. Valuation and Earnings This table compares Hyperfine and Arrayit"s revenue,
businesswire.com
Hyperfine, Inc. to Announce Fourth Quarter and Full Year 2025 Financial Results on March 18, 2026
GUILFORD, Conn.--(BUSINESS WIRE)--Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking health technology company that has redefined brain imaging with the first FDA-cleared AI-powered portable MRI system for the brain—the Swoop® system—today announced that it will report financial results for the fourth quarter and full year 2025 on Wednesday, March 18, 2026. Management will host a corresponding conference call at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time. A live audio webcast and an archiv.
defenseworld.net
Short Interest in Hyperfine, Inc. (NASDAQ:HYPR) Increases By 46.4%
Hyperfine, Inc. (NASDAQ: HYPR - Get Free Report) was the recipient of a large growth in short interest in the month of January. As of January 15th, there was short interest totaling 1,250,028 shares, a growth of 46.4% from the December 31st total of 854,005 shares. Based on an average trading volume of 487,628 shares, the
businesswire.com
Hyperfine Announces Publication of Breakthrough Clinical Data Demonstrating the Swoop® System's Enhanced Stroke Detection Capabilities
GUILFORD, Conn.--(BUSINESS WIRE)--Strong evidence supports the use of AI-powered portable MRI for stroke detection in multiple clinical settings, including the emergency department.
businesswire.com
Hyperfine Announces NEURO PMR Study Results Showing High Diagnostic Value and Superior Patient Experience in Neurology Clinics
GUILFORD, Conn.--(BUSINESS WIRE)--Results from the NEURO PMR study, presented by Dr. Laszlo Mechtler at the ASN Annual Meeting in San Juan, Puerto Rico, on January 16, 2026.
prnewswire.com
Bedside Breakthrough: AI Brings MRI-Precision to Every Clinic
/PRNewswire/ -- The medical imaging world is hitting a massive reset button as AI-driven clinical intelligence transforms how we map the human heart. With the
businesswire.com
Hyperfine Announces Enrollment of First Patient in Study to Expand Intended Use of the Swoop® System with Contrast Agents
GUILFORD, Conn.--(BUSINESS WIRE)--Prospective study is designed to evaluate the feasibility and visualization benefits of contrast-enhanced ultra-low-field portable MRI.
businesswire.com
Hyperfine Reports Preliminary, Unaudited Fourth Quarter and Full Year 2025 Financial Results
GUILFORD, Conn.--(BUSINESS WIRE)--Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking health technology company that has redefined brain imaging with the first FDA-cleared AI-powered portable MRI system for the brain—the Swoop® system—today announced preliminary, unaudited revenue, net cash burn, and cash and cash equivalents for the fourth quarter and full year ended December 31, 2025. Fourth Quarter 2025 Preliminary, Unaudited Financial Results Preliminary, unaudited revenue for the fourth qua.
businesswire.com
Hyperfine Announces First Peer-Reviewed Publication Demonstrating Significant Economic Benefits of Using the Swoop® AI-Powered Portable MRI System in Acute Hospital Care
GUILFORD, Conn.--(BUSINESS WIRE)--Hyperfine announces the first analysis showing the AI-powered Swoop® portable MRI system reduces hospital costs and improves economics in acute care.
defenseworld.net
Hyperfine, Inc. (NASDAQ:HYPR) Short Interest Update
Hyperfine, Inc. (NASDAQ: HYPR - Get Free Report) saw a significant decline in short interest in December. As of December 15th, there was short interest totaling 659,270 shares, a decline of 15.6% from the November 30th total of 780,752 shares. Currently, 1.0% of the shares of the stock are sold short. Based on an average daily
businesswire.com
Hyperfine Announces Regulatory Approval of the Swoop® System in India
GUILFORD, Conn.--(BUSINESS WIRE)--Swoop® portable MRI system receives CDSCO approval in India, expanding access to advanced brain imaging in a large, fast-growing healthcare market.
defenseworld.net
Hyperfine (NASDAQ:HYPR) Shares Down 6.8% – Should You Sell?
Hyperfine, Inc. (NASDAQ: HYPR - Get Free Report) dropped 6.8% during mid-day trading on Monday. The stock traded as low as $0.9250 and last traded at $0.9277. Approximately 3,219,550 shares changed hands during trading, an increase of 501% from the average daily volume of 536,113 shares. The stock had previously closed at $0.9959. Analyst Ratings
businesswire.com
Hyperfine Announces FDA Clearance of the First Optive AI™ Software Update with Advanced Diffusion Imaging Capability, Focused on Enhancing Stroke Detection with the Swoop® System
GUILFORD, Conn.--(BUSINESS WIRE)--Hyperfine secures FDA clearance for new DWI sequence, significantly expanding the Swoop® system's clinical capabilities in acute neurological care.
businesswire.com
Hyperfine, Inc. to Participate in Upcoming Piper Sandler 37th Annual Healthcare Conference
GUILFORD, Conn.--(BUSINESS WIRE)--Hyperfine announces plans to present at the upcoming Piper Sandler 37th Annual Healthcare Conference on Thursday, December 4th at 8:10 AM ET.
businesswire.com
Hyperfine Awarded $3.7 Million Grant to Advance Global Brain Health
GUILFORD, Conn.--(BUSINESS WIRE)--$3.7M grant supports expanded use of portable MRI to evaluate brain development and guide targeted health interventions in underserved communities.
defenseworld.net
Head to Head Review: Hyperfine (NASDAQ:HYPR) vs. Vasamed (OTCMKTS:VSMD)
Hyperfine (NASDAQ: HYPR - Get Free Report) and Vasamed (OTCMKTS:VSMD - Get Free Report) are both medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their analyst recommendations, valuation, institutional ownership, dividends, earnings, profitability and risk. Analyst Ratings This is a breakdown of recent recommendations for
seekingalpha.com
Hyperfine, Inc. (HYPR) Q3 2025 Earnings Call Transcript
Hyperfine, Inc. ( HYPR ) Q3 2025 Earnings Call November 13, 2025 4:30 PM EST Company Participants Webb Campbell Maria Sainz - CEO, President & Director Brett Hale - Chief Administrative Officer, CFO, Chief Compliance Officer, Treasurer & Corporate Secretary Conference Call Participants Frank Takkinen - Lake Street Capital Markets, LLC, Research Division Yuan Zhi - B. Riley Securities, Inc., Research Division Presentation Operator Good afternoon, and welcome to Hyperfine's Third Quarter 2025 Earnings Conference Call.
zacks.com
Hyperfine, Inc. (HYPR) Reports Q3 Loss, Tops Revenue Estimates
Hyperfine, Inc. (HYPR) came out with a quarterly loss of $0.11 per share versus the Zacks Consensus Estimate of a loss of $0.1. This compares to a loss of $0.14 per share a year ago.